- Home
- W vs IBRX Comparison
W vs IBRX Comparison
Compare W & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | W | IBRX |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.4B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | W | IBRX |
|---|---|---|
| Price | $71.84 | $7.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 28 | 7 |
| Target Price | ★ $105.82 | $12.57 |
| AVG Volume (30 Days) | 3.0M | ★ 22.6M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.15 | 38.71 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $113,288,000.00 |
| Revenue This Year | $7.39 | $88.59 |
| Revenue Next Year | $6.00 | $131.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 668.31 |
| 52 Week Low | $22.40 | $1.83 |
| 52 Week High | $119.98 | $12.43 |
Technical Indicators
Market Signals| Indicator | W | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 44.93 |
| Support Level | $70.59 | $5.89 |
| Resistance Level | $81.70 | $8.28 |
| Average True Range (ATR) | 4.31 | 0.94 |
| MACD | 0.38 | -0.19 |
| Stochastic Oscillator | 28.89 | 18.50 |
Price Performance
Historical ComparisonAbout W Wayfair Inc.
Wayfair engages in e-commerce in the United States (88% of 2025 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with 12 stores (excluding outlets) between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2025, the firm offered more than 40 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, as well as advertising and logistics services. Wayfair was founded in 2002 and began trading publicly in 2014.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.